Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000182071 | SCV000234374 | benign | not specified | 2014-10-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000182071 | SCV000270307 | likely benign | not specified | 2012-05-07 | criteria provided, single submitter | clinical testing | "Ala370Ala in Exon 08 of KCNQ1: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 2.3% (4/174) of chro mosomes from a population in the dbSNP database (http://www.ncbi.nlm.nih.gov/pro jects/SNP; rs1805118)." |
Labcorp Genetics |
RCV000228840 | SCV000283871 | benign | Long QT syndrome | 2024-01-13 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000352173 | SCV000370271 | likely benign | Atrial fibrillation, familial, 3 | 2018-09-12 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000385740 | SCV000370272 | likely benign | Jervell and Lange-Nielsen syndrome 1 | 2018-09-12 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000293658 | SCV000370273 | likely benign | Short QT syndrome type 2 | 2018-09-12 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001093991 | SCV000370274 | likely benign | Long QT syndrome 1 | 2018-09-12 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Color Diagnostics, |
RCV001842866 | SCV001343654 | benign | Cardiac arrhythmia | 2018-03-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002426876 | SCV002741420 | benign | Cardiovascular phenotype | 2021-04-16 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002492807 | SCV002796042 | likely benign | Atrial fibrillation, familial, 3; Beckwith-Wiedemann syndrome; Long QT syndrome 1; Jervell and Lange-Nielsen syndrome 1; Short QT syndrome type 2 | 2021-10-26 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000228840 | SCV004836382 | benign | Long QT syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004732754 | SCV005355602 | likely benign | KCNQ1-related disorder | 2024-05-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |